This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing various agents targeting BCMA and GPRC5D in multiple myeloma
Ticker(s): JNJ, LEGN, BMYWho's the expert?
Institution: University of Chicago
- Professor of Medicine & Director of Hematopoietic Cellular Therapy Program at the University of Chicago
- Currently manages ~50 active multiple myeloma patients.
- Research focuses on the prevention and treatment of relapse after stem cell transplantation; authored more than 150 peer-reviewed articles, in addition to more than 30 book chapters and two books on cancer treatment and research.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
